Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 21,400 shares, an increase of 57.4% from the July 31st total of 13,600 shares. Currently, 3.8% of the shares of the company are short sold. […]